维普期刊资源整合服务平台（V6.5）

24篇 您的检索式：作者名="Porter MD"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Cost and Utilization Impact of a Clinical Pathway for Patients Undergoing Pancreaticoduodenectomy显示文摘	Geoffrey A. Porter MD Peter W. T. Pisters MD Carol Mansyur MA Annette Bisanz MPH Kim Reyna MBA Pam Stanford RN Jeffrey E. Lee MD Douglas B. Evans MD	2000	Annals of Surgical Oncology2000，，7：	1
2	Expression of platelet-derived growth factor B-chain and the of platelet-derived growth factor B-chain and the platelet-clerived growth factor receptor beta subunit in human breast tissue and breast concinoma 显示文摘	Coltrera MD Wang J Porter PL	1995	Cancer Res1995，55，3：	1
3	Characterization ofa novel endocannabinoid,virodhamine,with antagonist activi- ty at the CB1 receptor 显示文摘	Porter AC Saner JM Knierman MD	2002	J Pharmacol Exp Ther2002，301，3：	1
4	Fabrication of porous Calcium polyphosphate implants by solid freeform fabrication: a study of processing parameters and in vitro degradation characteristics显示文摘	Porter NL Pilliar RM Grynpas MD	2001	J Biomed Mater Res2001，56，4：	1
5	Continued im- provement in myocardial T2* over two years of deferasirox thera- py in ~-thalassemia major patients with cardiac iron overload 显示文摘	Pennell DJ Porter JB Cappellini MD	2011	Haematologica2011，96，1：	1
6	Microminiaturized immunoassays using atomic force microscopy and compositionally patterned antigen arrays显示文摘	Jones VW Kenseth JR Porter MD	1998	Anal Chem1998，70，7：	1
7	Characterization of a novel endocannabinoid,virodhamine,with antagonist activity at the CB1 receptor显示文摘	Porter AC Sauer JM Knierman MD	2002	J Pharmacol Exp Ther2002，301，3：	1
8	Tai- loring iron chelation by iron intake and serum ferritin: the pro- spective EPIC study of deferasirox in 1744 patients with transfu- sion-dependent anemias 显示文摘	CAPPELLINI MD PORTER J E1-BESHLAWY A	2010	ltaematologica2010，95，4：	1
9	Expression of platelet- derived growth factor B-chain and the platelet-derived growth factor receptor beta subunit in human breast tissue and breast carcinoma 显示文摘	Cohrera MD Wang J Porter PL	1995	Cancer Res1995，55，12：	1
10	Continued improve- ment in myocardial T2* over two years of deferasirox therapy in β-thalassemia major patients with cardiac iron nverload 显示文摘	Pennell DJ Porter JB Cappellini MD	2011	Haematologica2011，96，1：	1
11	Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemia 显示文摘	PENNELL DJ PORTER JB CAPPELLINI MD	2010	Blood2010，115，12：	1
12	Effcacy and safety of deferasirox (Exjade) in reducing cardiac iron in pa- tients with b-thalassemia major: results from the Cardiac Sub- study of the EPIC trial 显示文摘	PENNELL D PORTER JB CAPPELLINI MD	2008	Blood2008，112，11：	1
13	Fabrication of porous calcium polyphosphate implants by solid freeform fabrication:a stu dy of processing parameters and in vitro degradation characteristics显示文摘	Porter NL Pilliar RM Grynpas MD	2001	J Biomed Mater Res2001，56，4：	1
14	Risk of diagnosed fractures in children with inflammatory bowel diseases 显示文摘	Kappelman MD Galanko JA Porter CQ	2011	Inflamm Bowel Dis2011，17，5：	1
15	Continued improvement in myocardial T2 * over two years of deferasirox therapy in !3-thalassemia major patients with cardiac iron overload显示文摘	Pennell DJ Porter JB Cappellini MD Chart LL EI-Beshlawy A Aydinok Y	2011	Haematologica2011，96，1：	1
16	Tailoring iron che\|ation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias显示文摘	Cappellini MD Porter J E1-Beshlawy A Li CK Seymour JF Elalfy M	2010	Haematologica2010，95，4：	1
17	Colofimetric-solid phase ex- traction method for trace level determination of arsenite in water 显示文摘	Bradley MM Siperko LM Porter MD	2011	Talanta2011，86，：	1
18	Thermodynamically controlled electrochemical formation of thiolate monolayers at gold: characterization and comparison to self-assembled analogs 显示文摘	Weisshaar DE Lamp BD Porter MD	1992	J Am Chem Soc1992，114，：	1
19	Tailoring iron chela-tion by iron intake and serum ferritin:the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias显示文摘	Cappellini MD Porter J El-Beshlawy A		0，，04：	1
20	Continued improve-ment in myocardial T2* over two years of deferasirox therapy in b-thalassemia major patients with cardiac iron overload显示文摘	Pennell DJ Porter JB Cappellini MD		0，，01：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示